At Fritsche Capital Group, our foremost objective is always to seek out earlier to mid-stage, technology-based life science and information technology companies where we have the ability to play a significant role in their corporate development and structure, while simultaneously providing our investor base with the potential to achieve long term, superior rates of internal return. To do this, we look for companies where the management team presents ideas, expertise, and individual qualities that we believe will provide for significant long term growth and market leadership through creativity, vision, innovation, and an unyielding desire to succeed – qualities that we believe are inherent to our structure and focus at Fritsche Capital Group.

Further, to insure we maintain an absolutely current perspective on trends in the venture capital and other private equity markets, FCG maintains an active role in numerous professional organizations. Among these organizations are the Medical Device Network at Stanford University, the Stanford Biodesign Network, Los Angeles Venture Association, the Colorado BioScience Association, the Rockies Venture Group in Denver, the MIT Forum and the Association of Investment Management and Research (AIMR).